BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

438 hedge funds and large institutions have $15.8B invested in BioMarin Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 150 increasing their positions, 145 reducing their positions, and 44 closing their positions.

Holders
438
Holders Change
+27
Holders Change %
+6.57%
% of All Funds
9.95%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.27%
New
78
Increased
150
Reduced
145
Closed
44
Calls
$208M
Puts
$155M
Net Calls
+$52.8M
Net Calls Change
+$34.5M

Top Buyers

1
MNG
1
Manning & Napier Group
New York
$177M
2
BBA
2
Baker Bros. Advisors
New York
$676M
3
BlackRock
3
BlackRock
New York
$1.14B
4
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$156M
5
Citadel Advisors
5
Citadel Advisors
Florida
$206M

Top Sellers

1
IG
1
Ithaka Group
Virginia
$5.37M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$532M
3
SIG
3
Senator Investment Group
New York
$0
4
O
4
OrbiMed
New York
$8.97M
5
Jennison Associates
5
Jennison Associates
New York
$1.05B
Name Market Value Shares Shares
Change 		Shares
Change %
Capital Research Global Investors
1
Capital Research Global Investors
California
$1.92B 21,500,859 +650,258 +3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.31B 14,735,730 +185,050 +1%
BlackRock
3
BlackRock
New York
$1.14B 12,819,744 +937,183 +8%
Jennison Associates
4
Jennison Associates
New York
$1.05B 11,809,695 -504,662 -4%
Primecap Management
5
Primecap Management
California
$914M 10,245,295 +606,651 +6%
Sands Capital Management
6
Sands Capital Management
Virginia
$689M 7,726,778 -331,781 -4%
BBA
7
Baker Bros. Advisors
New York
$676M 7,583,084 +1,677,411 +28%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$532M 5,970,333 -2,049,058 -26%
Invesco
9
Invesco
Georgia
$402M 4,513,641 +24,250 +0.5%
State Street
10
State Street
Massachusetts
$356M 3,994,575 -19,693 -0.5%
Temasek Holdings
11
Temasek Holdings
Singapore
$310M 3,472,712 – –
Goldman Sachs
12
Goldman Sachs
New York
$256M 2,865,502 +506,352 +21%
PAI
13
Palo Alto Investors
California
$223M 2,497,806 +59,287 +2%
WRF
14
Waddell & Reed Financial
Kansas
$218M 2,447,876 +66,102 +3%
T. Rowe Price Associates
15
T. Rowe Price Associates
Maryland
$216M 2,422,414 +413,363 +21%
Citadel Advisors
16
Citadel Advisors
Florida
$206M 2,315,075 +671,639 +41%
MNG
17
Manning & Napier Group
New York
$177M 1,980,877 +1,980,877 New
Balyasny Asset Management
18
Balyasny Asset Management
Illinois
$156M 1,751,391 +689,779 +65%
TCIM
19
TIAA CREF Investment Management
New York
$155M 1,736,686 -410,022 -19%
Franklin Resources
20
Franklin Resources
California
$153M 1,710,572 +80,568 +5%
Bank of America
21
Bank of America
North Carolina
$152M 1,706,339 -501,215 -23%
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$141M 1,582,785 +102,061 +7%
Capital World Investors
23
Capital World Investors
California
$130M 1,454,610 +227,456 +19%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$130M 1,452,492 -392,401 -21%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$129M 1,446,179 +19,011 +1%
1
2 3 4 5